Table 1.
Epidemiologic and clinical characteristics of controls and 5 groups supplemented with different concentrations of MT
| MT concentration (nM) | Number of oocytes/patients | Age (years) | BMI | Basal FSH (IU/ml) | Total Gn dose (IU) | Immature oocyte rate (%) |
|---|---|---|---|---|---|---|
| Control | 121/73 | 28.55 ± 4.63 | 23.68 ± 3.73 | 7.34 ± 2.82 | 2037.05 ± 879.23 | 86.5 ± 5.82 |
| 10−2 | 129/73 | 28.12 ± 5.20 | 23.41 ± 3.24 | 7.45 ± 2.20 | 2090.25 ± 902.33 | 86.7 ± 5.88 |
| 1 | 140/73 | 29.22 ± 4.45 | 22.23 ± 2.95 | 7.50 ± 2.58 | 1938.78 ± 850.65 | 85.6 ± 6.90 |
| 102 | 110/73 | 29.45 ± 4.61 | 22.53 ± 3.74 | 7.65 ± 2.49 | 2075.45 ± 912.36 | 85.0 ± 6.39 |
| 105 | 115/73 | 28.59 ± 5.59 | 22.25 ± 3.08 | 8.02 ± 2.86 | 2020.53 ± 898.41 | 85.0 ± 6.16 |
| 107 | 114/73 | 28.89 ± 4.63 | 23.58 ± 3.12 | 8.06 ± 2.68 | 1998.25 ± 890.02 | 84.7 ± 7.07 |